Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51-59-2

Post Buying Request

51-59-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51-59-2 Usage

Chemical Properties

Light-Borwn Cyrstals

Uses

Different sources of media describe the Uses of 51-59-2 differently. You can refer to the following data:
1. A metabolite of Mesalazine. A Salicylic Acid derivative. Inhibitor of recombinant human thiopurine methyltransferase (hTPMT)
2. A labelled metabolite of Mesalazine. A labelled Salicylic Acid derivative. Inhibitor of recombinant human thiopurine methyltransferase (hTPMT)
3. N-Acetyl Mesalazine is an metabolite of Mesalazine. A Salicylic Acid derivative. Inhibitor of recombinant human thiopurine methyltransferase (hTPMT).

Check Digit Verification of cas no

The CAS Registry Mumber 51-59-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 51-59:
(4*5)+(3*1)+(2*5)+(1*9)=42
42 % 10 = 2
So 51-59-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO4/c1-5(11)10-6-2-3-8(12)7(4-6)9(13)14/h2-4,12H,1H3,(H,10,11)(H,13,14)

51-59-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-acetamido-2-hydroxybenzoic acid

1.2 Other means of identification

Product number -
Other names Benzoic acid, 5-(acetylamino)-2-hydroxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51-59-2 SDS

51-59-2Synthetic route

5-Aminosalicylic Acid
89-57-6

5-Aminosalicylic Acid

acetic anhydride
108-24-7

acetic anhydride

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
With acetic acid In water for 0.5h; Reflux;94%
In water; acetone at 20℃; for 1.33333h; Reflux;94%
With multi-walled carbonnanotubes functionalized with phosphonic acid In neat (no solvent) at 20℃; for 0.333333h;90%
acetamide
60-35-5

acetamide

5-Aminosalicylic Acid
89-57-6

5-Aminosalicylic Acid

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
Stage #1: acetamide With thionyl chloride In diethyl ether
Stage #2: 5-Aminosalicylic Acid for 0.133333h; Heating;
84%
5-Aminosalicylic Acid
89-57-6

5-Aminosalicylic Acid

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
With acetic anhydride In water67%
Multi-step reaction with 2 steps
1: 36 h / 25 °C
2: NaOH / H2O / 2 h / 25 °C
View Scheme
5-acetylamino-2-bromobenzoic acid
22921-67-1

5-acetylamino-2-bromobenzoic acid

recorcinol
108-46-3

recorcinol

A

3-acetylaminobenzoic acid
587-48-4

3-acetylaminobenzoic acid

B

8-acetamide-3-hydroxy-6H-benzo-[c]-chromene-6-one

8-acetamide-3-hydroxy-6H-benzo-[c]-chromene-6-one

C

C15H13NO5

C15H13NO5

D

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
With lithium carbonate; copper(II) sulfate In water at 60℃; Reagent/catalyst; Temperature;A 15%
B 48%
C 11%
D 13%
5-nitrosalicylic acid
96-97-9

5-nitrosalicylic acid

A

5-Aminosalicylic Acid
89-57-6

5-Aminosalicylic Acid

B

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
With tin; acetic acid dann verduennt man mit Wasser und faellt mit Schwefelwasserstoff;
With tin; acetic acid
5-acetamido-2-acetoxybenzoic acid
6376-29-0

5-acetamido-2-acetoxybenzoic acid

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
With sodium hydroxide In water at 25℃; for 2h; Yield given;
5-nitrosalicylic acid
96-97-9

5-nitrosalicylic acid

acetic acid
64-19-7

acetic acid

tin

tin

A

5-Aminosalicylic Acid
89-57-6

5-Aminosalicylic Acid

B

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
5-(4'-sulphophenylazo)salicylic acid sodium salt

5-(4'-sulphophenylazo)salicylic acid sodium salt

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 71 percent / Na2S2O4; sodium hydroxide / H2O / 0.01 h / microwave irradiation
2.1: thionyl chloride / diethyl ether
2.2: 84 percent / 0.13 h / Heating
View Scheme
2-hydroxy-5-phenylazo-benzoic acid
3147-53-3

2-hydroxy-5-phenylazo-benzoic acid

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrosulfite sodium
2: alkali; water
View Scheme
salicylic acid
69-72-7

salicylic acid

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: glacial acetic acid; fuming nitric acid
2: tin; glacial acetic acid
View Scheme
Multi-step reaction with 2 steps
1: glacial acetic acid; lead nitrate
2: tin; glacial acetic acid
View Scheme
sebacoyl chloride
111-19-3

sebacoyl chloride

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

1,10-bis-5-acetamidosalicyl-sebacate
377064-84-1

1,10-bis-5-acetamidosalicyl-sebacate

Conditions
ConditionsYield
Stage #1: sebacoyl chloride; N-Acetyl-5-aminosalicylic acid With pyridine In tetrahydrofuran at 0℃; for 6.16667h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water pH=2;
96%
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

C9H6(2)H3NO4

C9H6(2)H3NO4

Conditions
ConditionsYield
With 10% Pt/activated carbon; palladium 10% on activated carbon; hydrogen; water-d2 at 145℃; for 24h; Sealed tube; regioselective reaction;95%
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

N-butylamine
109-73-9

N-butylamine

5-acetamido-N-butylsalicylamide
6382-44-1

5-acetamido-N-butylsalicylamide

Conditions
ConditionsYield
Stage #1: N-Acetyl-5-aminosalicylic acid With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 0℃; for 0.5h;
Stage #2: N-butylamine In N,N-dimethyl-formamide at 0 - 20℃;
86%
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

1,2:5,6-di-O-isopropylidene-α-D-glucofuranose
582-52-5

1,2:5,6-di-O-isopropylidene-α-D-glucofuranose

3-O-N-acetyl-5-aminosalicylate-1,2:5,6-di-O-isopropylidene-D-glucofuranose

3-O-N-acetyl-5-aminosalicylate-1,2:5,6-di-O-isopropylidene-D-glucofuranose

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h; Cooling with ice;57%
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

6-O-[5-(acetylamino)-2-hydroxybenzoyl]-1,2:3,4-di-O-isopropylidene-D-galactopyranose

6-O-[5-(acetylamino)-2-hydroxybenzoyl]-1,2:3,4-di-O-isopropylidene-D-galactopyranose

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h;51%
2,3;4,5-di-O-isopropylidene-β-D-fructopyranose
20880-92-6

2,3;4,5-di-O-isopropylidene-β-D-fructopyranose

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

1-O-[5-(acetylamino)-2-hydroxybenzoyl]-2,3:4,5-di-O-isopropylidene-D-fructopyranose

1-O-[5-(acetylamino)-2-hydroxybenzoyl]-2,3:4,5-di-O-isopropylidene-D-fructopyranose

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h;48%
2,3,4,5-di-O-isopropylidene-D-xylitol
30737-85-0

2,3,4,5-di-O-isopropylidene-D-xylitol

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

1-O-N-acetyl-5-aminosalicylate-2,3,4,5-di-isopropylidene-D-xylitol

1-O-N-acetyl-5-aminosalicylate-2,3,4,5-di-isopropylidene-D-xylitol

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h; Cooling with ice;47%
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

5-acetylamino-3-amino-2-hydroxy-benzoic acid

5-acetylamino-3-amino-2-hydroxy-benzoic acid

Conditions
ConditionsYield
With sulfuric acid; nitric acid man reduziert das Produkt mit Eisen und Essigsaeure;
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

2,6-dinitro-4-acetylaminophenol
118828-85-6

2,6-dinitro-4-acetylaminophenol

Conditions
ConditionsYield
With nitric acid
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

aniline
62-53-3

aniline

acetic acid-[4-hydroxy-3-(phenylimino-methyl)-anilide]

acetic acid-[4-hydroxy-3-(phenylimino-methyl)-anilide]

Conditions
ConditionsYield
With sodium hydroxide; boric acid; sodium chloride anschliessend Behandeln mit Natrium-Amalgam;
4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

6-acetylamino-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-benzo[e][1,3]oxazine-2,4-dione
14780-48-4

6-acetylamino-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
propylamine
107-10-8

propylamine

N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

6-acetylamino-3-propyl-benzo[e][1,3]oxazine-2,4-dione
14780-41-7

6-acetylamino-3-propyl-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

NCI 50119
1925-98-0

NCI 50119

Conditions
ConditionsYield
With ammonia; triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

ethylamine
75-04-7

ethylamine

6-acetylamino-3-ethyl-benzo[e][1,3]oxazine-2,4-dione
14714-12-6

6-acetylamino-3-ethyl-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

phenethylamine
64-04-0

phenethylamine

6-acetylamino-3-phenethyl-benzo[e][1,3]oxazine-2,4-dione
14780-46-2

6-acetylamino-3-phenethyl-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

isopropylamine
75-31-0

isopropylamine

6-acetylamino-3-isopropyl-benzo[e][1,3]oxazine-2,4-dione
14780-42-8

6-acetylamino-3-isopropyl-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

1,1-dimethylhydrazine
57-14-7

1,1-dimethylhydrazine

6-acetylamino-3-dimethylamino-benzo[e][1,3]oxazine-2,4-dione
14780-50-8

6-acetylamino-3-dimethylamino-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

N,N-dimethylethylenediamine
108-00-9

N,N-dimethylethylenediamine

6-acetylamino-3-(2-dimethylamino-ethyl)-benzo[e][1,3]oxazine-2,4-dione
14780-43-9

6-acetylamino-3-(2-dimethylamino-ethyl)-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

6-acetylamino-3-(2-diethylamino-ethyl)-benzo[e][1,3]oxazine-2,4-dione

6-acetylamino-3-(2-diethylamino-ethyl)-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

4-Ethoxyaniline
156-43-4

4-Ethoxyaniline

6-acetylamino-3-(4-ethoxy-phenyl)-benzo[e][1,3]oxazine-2,4-dione
14780-47-3

6-acetylamino-3-(4-ethoxy-phenyl)-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

1-amino-2-propene
107-11-9

1-amino-2-propene

6-acetylamino-3-allyl-benzo[e][1,3]oxazine-2,4-dione
14792-97-3

6-acetylamino-3-allyl-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

methoxycarbonylmethylamine
616-34-2

methoxycarbonylmethylamine

(6-acetylamino-2,4-dioxo-4H-benzo[e][1,3]oxazin-3-yl)-acetic acid methyl ester
14780-49-5

(6-acetylamino-2,4-dioxo-4H-benzo[e][1,3]oxazin-3-yl)-acetic acid methyl ester

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

2,6-dimethylaniline
87-62-7

2,6-dimethylaniline

6-acetylamino-3-(2,6-dimethyl-phenyl)-benzo[e][1,3]oxazine-2,4-dione
14714-11-5

6-acetylamino-3-(2,6-dimethyl-phenyl)-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

methylamine
74-89-5

methylamine

6-acetylamino-3-methyl-benzo[e][1,3]oxazine-2,4-dione
14780-38-2

6-acetylamino-3-methyl-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine
N-Acetyl-5-aminosalicylic acid
51-59-2

N-Acetyl-5-aminosalicylic acid

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

5-diethylamino-2-pentylamine
140-80-7

5-diethylamino-2-pentylamine

6-acetylamino-3-(4-diethylamino-1-methyl-butyl)-benzo[e][1,3]oxazine-2,4-dione

6-acetylamino-3-(4-diethylamino-1-methyl-butyl)-benzo[e][1,3]oxazine-2,4-dione

Conditions
ConditionsYield
With triethylamine

51-59-2Relevant articles and documents

Scalable synthesis of 8-amino-3-hydroxy-6 H -benzo[ c ]chromen-6-one: Key intermediate for SEGRA via the Hurtley reaction

Kudo, Kazuhiro,Yamamoto, Noriyoshi

, p. 309 - 314 (2015)

A practical and scalable process for the preparation of 8-amino-3-hydroxy-6H-benzo[c]chromen-6-one in multihundred kilogram amounts has been developed. The key features of this synthesis are the application of the Hurtley reaction with a copper and base combination and the development of a purification process. The new synthesis improved the total yield from 49.0% to 59.5% and reduced the number of steps from three to two. Compared with the conventional medicinal route, manufacturing costs were reduced significantly by the use of inexpensive, easy to procure materials.

Liposomal formulations of inflammatory bowel disease drugs: Local versus systemic drug delivery in a rat model

Kesisoglou, Filippos,Zhou, Simon Yuji,Niemiec, Susan,Lee, Jordan Wing,Zimmermann, Ellen M.,Fleisher, David

, p. 1320 - 1330 (2005)

Purpose. Based on adherence to intestinal mucosa, intralumenally administered liposomal formulations of 5-aminosalicylate (5-ASA) and 6-mercaptopurine (6-MP) were studied for their potential to enhance local drug delivery to intestinal tissue for the treatment of inflammatory bowel disease. Methods. 5-ASA was encapsulated in standard phospholipid liposomes while 6-MP required encapsulation in nonphospholipid liposomes to obtain equivalent drug loading. Encapsulation efficiency was measured by size-exclusion chromatography/high-performance liquid chromatogtaphy (HPLC). Liposomal formulations or solution of the drugs were injected into unligated jejunum to compare pharmacokinetics and into ligated loops of rat ileum and colon to evaluate local delivery. Dextran sulfate and acetic acid induced colitis were used as models of lower intestinal inflammation. Plasma, tissue and luminal drug and metabolite levels were measured by liquid scintillation counting or HPLC. Results. Encapsulation efficiency of 6-MP was dependent on lipid content and composition. While liposomal encapsulation significantly reduced systemic absorption of 5-ASA this was not the case for 6-MP. Liposomal adherence to intestinal tissue resulted in increased tissue levels for 5-ASA; however, 6-MP local tissue levels were not improved compared to solution drug. Conclusions. Nonphospholipid liposomes optimize encapsulation of 6-MP. While liposomal formulations show potential for local drug delivery to diseased bowel, drug physicochemical properties, absorption, and metabolic profiles dictate tissue-targeting potential. Liposomes reduce systemic availability from paracellular absorption of hydrophilic 5-ASA, but fail to improve local tissue delivery of 6-MP, a molecule absorbed by passive membrane permeation that undergoes extensive first- pass metabolism.

Synthesis and in?vitro Bioactivity Evaluation of New Galactose and Fructose Ester Derivatives of 5-Aminosalicylic Acid

Yousefi, Samira,Bayat, Saadi,Rahman, Mohd Basyaruddin Abdul,Ibrahim, Zalikha,Abdulmalek, Emilia

, (2017/04/18)

Inflammatory bowel disease (IBD) is the main risk factor for developing colorectal cancer which is common in patients of all ages. 5-Aminosalicylic acid (5-ASA), structurally related to the salicylates, is highly active in the treatment of IBD with minor side effects. In this study, the synthesis of galactose and fructose esters of 5-ASA was planned to evaluate the role of glycoconjugation on the bioactivity of the parent drug. The antibacterial activity of the new compounds were evaluated against two Gram-negative and two Gram-positive species of bacteria, with a notable effect observed against Staphylococcus aureus and Escherichia coli in comparisons with the 5-ASA. Cytotoxicity testing over HT-29 and 3T3 cell lines indicated that the toxicity of the new products against normal cells was significantly reduced compared with the original drug, whereas their activity against cancerous cells was slightly decreased. The anti-inflammatory activity test in RAW264.7 macrophage cells indicated that the inhibition of nitric oxide by both of the monosaccharide conjugated derivatives was slightly improved in comparison with the non-conjugated drug.

Preparation and characterization of multi-walled carbon nanotubes (MWCNTs), functionalized with phosphonic acid (MWCNTs-C-PO3H2) and its application as a novel, efficient, heterogeneous, highly selective and reusable catalyst for acetylation of alcohols, phenols, aromatic amines, and thiols

Dehghani, Farzaneh,Sardarian, Ali Reza,Doroodmand, Mohammad Mehdi

, p. 673 - 684 (2014/05/20)

A novel, efficient, heterogeneous, and reusable multi-walled carbon nanotubes (MWCNTs), functionalized with phosphonic acid (MWCNTs-C-PO 3H2) has been synthesized. The synthesized CNTs were characterized using some electron microscopic techniques such as scanning electron microscopy (SEM), atomic force microscopy (AFM), Energy dispersive X-ray spectroscopy (EDAX), and also some thermal and spectroscopic methods such as thermogravimetry (TG). The nitrogen adsorption behavior of the MWCNTs-C-PO3H2 catalyst was evaluated using the TG instrumentation system at 25°C. The catalyst was applied successfully for highly efficient and selective acetylation of alcohols, phenols, thiols and aromatic amines with acetic anhydride at room temperature under solvent-free conditions. The reusability of the catalyst was checked and the recovered catalyst was reused for five runs without significant loss in activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51-59-2